Director Yang buys 2,000 shares at $12.90 as PCRX stock falls -67.1% from 52-week high; 3 other insiders bought within 14 days
Michael J. Yang, a director, purchased 2,000 shares at $12.90, representing a 38.2% increase to his holdings of 7.2K shares. This transaction occurs within a 14-day window containing three other insider purchases at the same company, forming a cluster buy pattern. The stock has declined substantially, trading -67.1% from the 52-week high of $37.88, -41.5% over 30 days, and -60.4% over 90 days, and currently sits at $12.47, just above the 52-week low of $11.70. While fundamentals show positive net income of $18.9M on revenue of $178.0M and a low P/E of 9.04, the concurrent buying by multiple insiders during a sharp price decline merits investor scrutiny to distinguish between opportunistic accumulation at depressed prices versus broader concerns about valuation or near-term catalysts that insiders may perceive.